Delivery Order SPE2DB20D3505-SPE2DB21FU5C9
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,092.50 firm fixed-price delivery order is for the supply of 4,561,489,120 milliliters of Nitrofurantoin 25 mg/5 ml suspension, a medication used to treat urinary tract infections. The contract has a period of performance through July 14, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Nitrofurantoin 25 mg/5 ml suspension (240 ml). The contract, valued at $12,073.45, is a firm-fixed-price delivery order with an ultimate completion date of December 27, 2023. The contract was awarded on December 26, 2023, and there was no set-aside designation used. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The award, valued at $5,183.25, is a delivery order contract with a firm fixed price. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 1, 2024. The contract does not have a set-aside designation, indicating it was awarded through full and open...
- This federal contract award is for the delivery of Nitrofurantoin 25 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract, valued at $24,662.14, is a delivery order with a firm fixed price. It does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $16,243.75, is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The contract has an ultimate completion date of May 16, 2023 and is a Firm Fixed Price Delivery Order. The contract is not set-aside and was awarded through full and open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award, valued at $22,066.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company. The contract is for the delivery of Nitrofurantoin 25 mg/5 ml suspension, a medication used for the treatment of urinary tract infections. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has extensive experience in supplying pharmaceutical products and medical supplies to various...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,331.51 Firm Fixed Price Delivery Order is for the supply of 240 mL bottles of Nitrofurantoin 25 mg/5 mL oral suspension, a medication used to treat urinary tract infections. The contract has an ultimate completion date of August 11, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, SPE2DX15D1053|SPE2DX24F6CLS, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $20,523.53 firm-fixed-price delivery order is for the supply of 240 ml bottles of 25 mg/5 ml Nitrofurantoin suspension. The contract has a completion date of November 8, 2023 and was awarded on November 7, 2023. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract...
- This federal contract award, valued at $30,697.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,182,939 units of Nitrofurantoin Mono-MCR 100 mg medication to support federal healthcare programs. The award is a firm-fixed-price delivery order with a completion date of December 28, 2023. This contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,159.86 Firm Fixed Price Delivery Order contract provides for the supply of 4566188072 NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. The award has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB21FU5C9Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order valued at $12,442.59 for the supply of Nitrofurantoin 25 mg/5 ml suspension, a pharmaceutical product used to treat urinary tract infections. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 that runs through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition, Amerisourcebergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation valued up to $750,000 through May 2024 for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 9/29/21 |